ZA914676B - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
ZA914676B
ZA914676B ZA914676A ZA914676A ZA914676B ZA 914676 B ZA914676 B ZA 914676B ZA 914676 A ZA914676 A ZA 914676A ZA 914676 A ZA914676 A ZA 914676A ZA 914676 B ZA914676 B ZA 914676B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
ZA914676A
Other languages
English (en)
Inventor
William Pendergast
Pendergast William
Scott Howard Dickerson
Howard Dickerson Scott
Julius Vass Johnson
Vass Johnson Julius
Robert Ferone
Ferone Robert
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA914676B publication Critical patent/ZA914676B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
ZA914676A 1990-06-19 1991-06-18 Pharmaceutical compounds ZA914676B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ZA914676B true ZA914676B (en) 1993-02-24

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914676A ZA914676B (en) 1990-06-19 1991-06-18 Pharmaceutical compounds

Country Status (26)

Country Link
US (4) US6090941A (ja)
EP (2) EP0535034B1 (ja)
JP (1) JP2966929B2 (ja)
KR (1) KR0183042B1 (ja)
CN (1) CN1049215C (ja)
AP (1) AP218A (ja)
AT (2) ATE260262T1 (ja)
AU (1) AU639815B2 (ja)
CA (1) CA2085589C (ja)
CS (1) CS186391A3 (ja)
DE (2) DE69133371T2 (ja)
DK (2) DK1199307T3 (ja)
ES (2) ES2178632T3 (ja)
FI (1) FI925778A (ja)
GB (1) GB9013615D0 (ja)
HU (2) HUT62273A (ja)
IE (1) IE912073A1 (ja)
IL (1) IL98542A (ja)
MC (1) MC2290A1 (ja)
MY (1) MY107001A (ja)
NO (1) NO924929L (ja)
NZ (1) NZ238582A (ja)
PL (1) PL169927B1 (ja)
PT (1) PT98021B (ja)
WO (1) WO1991019700A1 (ja)
ZA (1) ZA914676B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
WO2000055166A1 (en) 1999-03-16 2000-09-21 Regents Of The University Of California Glycosylated polyamines
KR100851957B1 (ko) * 2000-06-09 2008-08-12 오에스아이 파마슈티컬스, 인코포레이티드 벤조퀴나졸린 티미딜레이트 신타제 억제제의 리포솜 제형
EP1432710A1 (en) * 2001-09-26 2004-06-30 Bayer Pharmaceuticals Corporation 1, 8-naphthyridine derivatives as antidiabetics
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (en) 2005-08-17 2007-02-21 Dan Stoicescu Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
DK1969031T3 (da) 2005-12-05 2009-09-14 Nitto Denko Corp Polyglutamat-aminosyre-konjugater og fremgangsmåder
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
KR101129868B1 (ko) 2006-10-04 2012-04-12 화이자 프로덕츠 인코포레이티드 칼슘 수용체 길항제로서의 피리도［4,3-ｄ］피리미딘-4(3Ｈ)-온 유도체
EP1958632A1 (en) 2007-02-14 2008-08-20 Dan Stoicescu Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
EP2155255B1 (en) * 2007-05-09 2013-08-14 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
WO2008141110A2 (en) * 2007-05-09 2008-11-20 Nitto Denko Corporation Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
EP2155254B1 (en) * 2007-05-09 2012-11-28 Nitto Denko Corporation Polymers conjugated with platinum drugs
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8501242B2 (en) 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) * 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
ZA72442B (en) * 1971-02-05 1972-10-25 Apaw Sa Automatic ice-cream machine
DE3069468D1 (en) * 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds

Also Published As

Publication number Publication date
DK1199307T3 (da) 2004-06-14
NO924929D0 (no) 1992-12-18
ATE222243T1 (de) 2002-08-15
HU211265A9 (en) 1995-11-28
US6090941A (en) 2000-07-18
PT98021A (pt) 1992-04-30
MC2290A1 (fr) 1993-07-14
NZ238582A (en) 1993-12-23
US5661155A (en) 1997-08-26
EP0535034A1 (en) 1993-04-07
ES2178632T3 (es) 2003-01-01
EP1199307B1 (en) 2004-02-25
GB9013615D0 (en) 1990-08-08
PL169927B1 (pl) 1996-09-30
KR0183042B1 (ko) 1999-05-01
DE69133371T2 (de) 2005-01-27
HUT62273A (en) 1993-04-28
US5663337A (en) 1997-09-02
WO1991019700A1 (en) 1991-12-26
EP1199307A1 (en) 2002-04-24
FI925778A0 (fi) 1992-12-18
PT98021B (pt) 1998-11-30
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
DE69133088T2 (de) 2003-03-20
HU9204011D0 (en) 1993-03-29
DE69133088D1 (de) 2002-09-19
ES2211851T3 (es) 2004-07-16
CA2085589C (en) 2001-12-18
NO924929L (no) 1992-12-18
DE69133371D1 (de) 2004-04-01
EP0535034B1 (en) 2002-08-14
CN1049215C (zh) 2000-02-09
AP218A (en) 1992-09-27
JPH05507704A (ja) 1993-11-04
JP2966929B2 (ja) 1999-10-25
US6306865B1 (en) 2001-10-23
MY107001A (en) 1995-08-30
KR930701415A (ko) 1993-06-11
CS186391A3 (en) 1992-04-15
CN1058208A (zh) 1992-01-29
AU8094391A (en) 1992-01-07
DK0535034T3 (da) 2002-12-09
AU639815B2 (en) 1993-08-05
IE912073A1 (en) 1992-01-01
IL98542A0 (en) 1992-07-15
FI925778A (fi) 1992-12-18
IL98542A (en) 1995-05-26
CA2085589A1 (en) 1991-12-20

Similar Documents

Publication Publication Date Title
IL100091A0 (en) Pharmaceutical agents
PH30215A (en) Pharmaceutical compounds
AP9100283A0 (en) Pharmaceutical compounds
GB2269382B (en) Pharmaceutical compounds
HU9303261D0 (en) Pharmaceutical compounds
ZA931944B (en) Pharmaceutical compounds
GB9008123D0 (en) Pharmaceutical compounds
GB8916682D0 (en) Pharmaceutical compounds
GB9012252D0 (en) Pharmaceutical compounds
ZA938546B (en) Pharmaceutical compounds
GB9226724D0 (en) Pharmaceutical compounds
GB9000241D0 (en) Pharmaceutical use
ZA915933B (en) Pharmaceutical compounds
GB9004023D0 (en) Pharmaceutical compounds
GB9211379D0 (en) Pharmaceutical compounds
GB9007228D0 (en) Pharmaceutical compound
GB9121358D0 (en) Pharmaceutical compounds
GB9108742D0 (en) Pharmaceutical compounds
GB9107755D0 (en) Pharmaceutical compounds
GB9107754D0 (en) Pharmaceutical compounds
GB9107486D0 (en) Pharmaceutical compounds
GB9116593D0 (en) Pharmaceutical compounds
GB9124439D0 (en) Pharmaceutical compounds
GB9127442D0 (en) Pharmaceutical compounds
GB9218091D0 (en) Pharmaceutical compounds